Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 1;14(11-12):77-81.

Positive and Negative Syndrome Scale (PANSS) Training: Challenges, Solutions, and Future Directions

Mark G A Opler  1   2   3 , Christian Yavorsky  1   2   3 , David G Daniel  1   2   3
Affiliations
Review

Positive and Negative Syndrome Scale (PANSS) Training: Challenges, Solutions, and Future Directions

Mark G A Opler et al. Innov Clin Neurosci. .

Abstract

Rater training and the maintenance of the consistency of ratings are critical to ensuring reliability of study measures and sensitivity to changes in the course of a clinical trial. The Positive and Negative Syndrome Scale (PANSS) has been widely used in clinical trials of schizophrenia and other disorders and is considered the "gold standard" for assessment of antipsychotic treatment efficacy. The various features associated with training and calibration of this scale are complex, reflecting the intricacy and heterogeneity of the disorders that the PANSS is used to evaluate. In this article, the authors review the methods for ensuring reliability of the PANSS as well as a proposed trajectory for its use in the future. An overview of the current principles, implementation, technologies, and strategies for the best use of the PANSS; tips for how to achieve consistency among raters; and optimal training practices of this instrument are presented.

Keywords: PANSS; Positive and Negative Syndrome Scale; clinical trials; rater; rater training; technology.

PubMed Disclaimer

Conflict of interest statement

FUNDING:No funding was provided for this article. DISCLOSURES:Dr. Opler is a full-time employee and shareholder of MedAvante-ProPhase Inc. Dr. Yavorsky is a full-time employee of Cronos CCS. Dr. Daniel is a full-time employee and shareholder of Bracket Global, LLC.

References

    1. Sajatovic M, Gaur R, Tatsuoka C, et al. Rater training for a multisite, international clinical trial: What mood symptoms may be most difficult to rate? Psychopharmacol Bull. 2011;44(3):5–14. - PMC - PubMed
    1. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276. - PubMed
    1. Lindström E, Wieselgren IM, von Knorring L. Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia. Acta Psychiatr Scand. 1994;89(3):192–195. - PubMed
    1. Knorring LV, Lindström E. Principal components and further possibilities with the PANSS. Acta Psychiatrica Scandinavica. 1995;92(s388):5–10. - PubMed
    1. Napo F, Heinz A, Auckenthaler A. Explanatory models and concepts of West African Malian patients with psychotic symptoms. European Psychiatry. 2012;27(Suppl 2):S44–S49. - PubMed

LinkOut - more resources